Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

Arrowhead buys PRV for $215M; Twist hopes to raise $300M in public offering

๐Ÿ’ต Arrowhead Pharmaceuticals pays $215M for PRV: The drugmaker tucked into an SEC filing that it will pay that amount โ€” the highest price tag this year for a ...

We haven't written up this one. Endpoints News has the full story โ€” the link below goes straight to it.

Read the original at endpoints.news โ†’

More in Health & Medicine

More from Wednesday 5 August โ†’